63498 Federal Register / Vol. 75, No. 199 / Friday, October 15, 2010 / Notices 

Web site at http://www.ahrq.gov no later 

than November 1, 2010. 

Dated: October 5, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–25774 Filed 10–14–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Congenital 

Diaphragmatic Hernia. 

Date: November 9, 2010. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Neelakanta Ravindranath, 

PhD, Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Blvd., Room 5B01G, Bethesda, MD 20892, 

301–435–6889, ravindrn@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: October 6, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26029 Filed 10–14–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary 

and Alternative Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Clinical Review of 

R01s. 

Date: October 26, 2010. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Hungyi Shau, Scientific 

Review Officer, National Center for 

Complementary and Alternative Medicine, 

National Institutes of Health, 6707 

Democracy Boulevard, Suite 401, Bethesda, 

MD 20892, 301–402–1030, 

Hungyi.Shau@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: October 5, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26026 Filed 10–14–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Statistical Analysis in Support of DPMC 

Clinical Trials (8894). 

Date: October 27–28, 2010. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Courtyard by Marriott Rockville, 

2500 Research Boulevard, Rockville, MD 

20850. 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, lf33c.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos.: 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: October 6, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–26024 Filed 10–14–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary Delisting 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of delisting. 

SUMMARY: AHRQ has accepted a 

notification of voluntary relinquishment 

from the ACCE Healthcare Technology 

Foundation of its status as a Patient 

Safety Organization (PSO). The Patient 

Safety and Quality Improvement Act of 

2005 (Patient Safety Act), Public Law 

109–41, 42 U.S.C. 299b–21–b–26, 

provides for the formation of PSOs, 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of health care 

delivery. The Patient Safety and Quality 

Improvement Final Rule (Patient Safety 

Rule), 42 CFR part 3, authorizes AHRQ, 

on behalf of the Secretary of HHS, to list 

as a PSO an entity that attests that it 

meets the statutory and regulatory 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 199 / Friday, October 15, 2010 / Notices 63499 

1 Department of Homeland Security 

Appropriations Act, 2007, Pub. L. 109–925, see 

525(d) (October 4, 2006), on reenacted in the 

Department of Homeland Security Appropriations 

Act, 2008, Public Law 110–161 Div. E. Sec. 522 

(December 26, 2007); Department of Homeland 

Security Appropriations Act, 2009, Public Law 

110–329 D.V.D. sec. 510 (September 30, 2008), and 

Department of Security Appropriations Act 2010, 

Public Law 111.83, sec. 510 (October 29, 2009). 

requirements for listing. A P80 can be 

‘‘delisted’’ by the Secretary if it is found 

to no longer meet the requirements of 

the Patient Safety Act and Patient Safety 

Rule, including when a P80 1 chooses 

to voluntarily relinquish its status as a 

PSO for any reason. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12 Midnight 

ET(2400) on September 21, 2010. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: http:// 

www.pso.AHRQ.gov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Diane Cousins, RPh, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toIl free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; E-mail: 

pso@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity is to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. HHS issued the Patient Safety 

Rule to implement the Patient Safety 

Act. AHRQ administers the provisions 

of the Patient Safety Act and Patient 

Safety Rule (PDF file, 450 KB. PDF 

Help) relating to the listing and 

operation of PSOs. Section 3.108(d) of 

the Patient Safety Rule requires AHRQ 

to provide public notice when it 

removes an organization from the list of 

federally approved PSOs. AHRQ has 

accepted a notification from the ACCE 

Healthcare Technology Foundation, 

PSO number P0017, to voluntarily 

relinquish its status as a PSO. 

Accordingly, the ACCE Healthcare 

Technology Foundation was delisted 

effective at 12:00 Midnight ET (2400) on 

September 21, 2010. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/ 

index.html. 

Dated: October 1, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–25771 Filed 10–14–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HOMELAND 

SECURITY 

Transportation Security Administration 

Extension of Agency Information 

Collection Activity Under OMB Review: 

Sensitive Security Information Threat 

Assessments 

AGENCY: Transportation Security 

Administration, DHS. 

ACTION: 30 day notice. 

SUMMARY: This notice announces that 

the Transportation Security 

Administration (TSA) has forwarded the 

Information Collection Request (ICR), 

Office of Management and Budget 

(OMB) control number 1652–0042, 

abstracted below to OMB for review and 

approval of an extension of the 

currently approved collection under the 

Paperwork Reduction Act (PRA). The 

ICR describes the nature of the 

information collection and its expected 

burden. TSA published a Federal 

Register notice, with a 60-day comment 

period soliciting comments, of the 

following collection of information on 

July 30, 2010 75 FR 44974. The 

collection involves TSA determining 

whether the party or representative of a 

party seeking access to sensitive 

security information (SSI) in a civil 

proceeding in Federal court may be 

granted access to the SSI. 

DATES: Send your comments by 

November 15, 2010. A comment to OMB 

is most effective if OMB receives it 

within 30 days of publication. 

ADDRESSES: Interested persons are 

invited to submit written comments on 

the proposed information collection to 

the Office of Information and Regulatory 

Affairs, OMB. Comments should be 

addressed to Desk Officer, Department 

of Homeland Security/TSA, and sent via 

electronic mail to 

oira_submission@omb.eop.gov or faxed 

to (202) 395–6974. 

FOR FURTHER INFORMATION CONTACT: 

Joanna Johnson, TSA PRA Officer, 

Office of Information Technology (OIT), 

TSA–11, Transportation Security 

Administration, 601 South 12th Street, 

Arlington, VA 20598–6011; telephone 

(571) 227–3651; e-mail 

TSAPRA@dhs.gov. 

SUPPLEMENTARY INFORMATION: 

Comments Invited 

In accordance with the Paperwork 

Reduction Act of 1995 (44 U.S.C. 3501 

et seq.), an agency may not conduct or 

sponsor, and a person is not required to 

respond to, a collection of information 

unless it displays a valid OMB control 

number. The ICR documentation is 

available at http://www.reginfo.gov. 

Therefore, in preparation for OMB 

review and approval of the following 

information collection, TSA is soliciting 

comments to— 

(1) Evaluate whether the proposed 

information requirement is necessary for 

the proper performance of the functions 

of the agency, including whether the 

information will have practical utility; 

(2) Evaluate the accuracy of the 

agency’s estimate of the burden; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

collection of information on those who 

are to respond, including using 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Information Collection Requirement 

Title: Sensitive Security Information 

Threat Assessments. 

Type of Request: Extension of a 

currently approved collection. 

OMB Control Number: 1652–0042. 

Forms(s): TSA 2211. 

Affected Public: Individuals seeking 

access to SSI Information. 

Abstract: TSA has implemented 

Section 525 of the DHS Appropriations 

Act 1, 2007, Public Law 109–925, see 

525(d) (October 4, 2006), as reenacted in 

the Department of Homeland 

Appropriations Act, 2008, Public Law 

110–161, sec. 522 (Dec 26, 2007); 

Department of Homeland Security 

Appropriations, 2009, Public Law 110– 

329, D.V.D. sec. 510 (September 30, 

2008), and Department of Homeland 

Security Appropriations Act 2010, 

Public Law 111.83, sec. 510 (October 29, 

2009), by establishing a process 

whereby a party seeking access to SSI in 

a civil proceeding in federal court that 

demonstrates a substantial need for 

relevant SSI in preparation of the party’s 

case may request that the party 

representative or court reporter be 

granted access to the SSI. In order to 

determine if the individual may be 

granted access to SSI for this purpose, 

TSA conducts a criminal history records 

check (CHRC) and threat assessment. 

Individuals are required to submit 

information including identifying 

information and an explanation 

mstockstill on DSKH9S0YB1PROD with NOTICES